What Are the Effects of Stopping Wegovy?

What actually happens to appetite and weight when Wegovy is stopped?

Semaglutide keeps appetite suppressed by activating GLP-1 receptors in the brain and gut, slowing how quickly food leaves the stomach and increasing feelings of fullness. Once your last dose clears (semaglutide has a half-life of roughly a week, so it takes several weeks to leave your system fully) those signals are no longer reinforced.

The clinical picture from the STEP 1 trial extension is stark. Participants who stopped semaglutide 2.4mg at week 68 and were then observed for a further year regained, on average, around two-thirds of the weight they had originally lost. Cardiometabolic markers (blood pressure, waist circumference, blood sugar regulation) moved back toward baseline at a similar pace. The NHS medicines page for semaglutide notes this pattern and the reason behind it: obesity is a chronic condition, and stopping the treatment that was managing it tends to allow that condition to reassert itself.

None of this means the treatment failed. It means the treatment was working, and that the underlying biology has not changed. For many people, that reality shapes the conversation with their prescriber about how long to continue, and understanding how to manage weight gain after stopping Wegovy can help you prepare for that discussion. You can read more about how semaglutide affects the body during treatment if you want the fuller picture before deciding anything.

Are there side effects specifically caused by stopping Wegovy, or does it just fade?

Stopping Wegovy is not like stopping some medicines where abrupt withdrawal triggers a distinct physical reaction. There is no recognised semaglutide withdrawal syndrome. What people notice instead is a gradual return of hunger, cravings and interest in food that had become muted during treatment.

Some people find the return of appetite feels sharper than expected, especially if the suppression had been significant. Others notice their eating patterns feel harder to manage. This is not a side effect in the clinical sense; it is the absence of the medicine's effect. It can, however, feel abrupt and discouraging if you were not prepared for it.

The broader question of what semaglutide does to the body over time is worth understanding before stopping, because the metabolic gains built up during months of treatment (reduced inflammation markers, improved insulin sensitivity) are not permanent if weight is regained. For anyone considering a planned pause rather than a permanent stop, that conversation belongs with a prescriber.

One practical note: if you have been taking Wegovy alongside an oral contraceptive pill, your prescriber will have discussed contraception arrangements already. Worth double-checking if that conversation hasn't happened.

Does stopping Wegovy affect anything beyond weight?

Wegovy holds a UK licence for weight management, and in eligible adults it also reduces the risk of major cardiovascular events. Both benefits depend on the medicine being active in your system. Clinical trial data reported in the STEP 1 paper in the New England Journal of Medicine showed that improvements in blood pressure, cholesterol profiles and blood glucose tracked closely with weight change, in both directions. Lose weight, those numbers tend to improve; regain it, they tend to drift back.

There is no evidence that stopping semaglutide causes new metabolic harm directly. The risk is indirect: the weight and its associated conditions return. That is why NICE's guidance on semaglutide for weight management (TA875) positions it as a treatment that can run for up to two years within a specialist service, with a clear review of whether continuing is appropriate if less than 5% weight loss is achieved on the maintenance dose. The implication is that these medicines are intended to be part of a longer plan, not a short course.

If you stopped treatment and want to understand what the options are now, the guide to what happens after stopping Wegovy covers next steps in more detail, including re-starting questions.

Can you restart Wegovy after stopping, and what should you know first?

There is no clinical rule preventing a restart. Whether it is appropriate depends on your current health picture — weight, any comorbidities, what dose you were on and why you stopped. A prescriber will want to know the full story: did you stop because of side effects, because the medicine became unavailable, because you felt you had reached your goal, or for another reason? Each scenario changes the restart conversation.

If you stopped partway through the dose ramp rather than at maintenance, you may not need to return to the very beginning of the titration schedule, but equally you should not assume you can pick up where you left off without clinical input. The semaglutide dose escalation process exists to reduce gastrointestinal side effects; skipping steps after a gap carries the same risks it did the first time round.

For anyone thinking about re-starting or considering the practicalities of stopping Wegovy properly, the right starting point is a conversation with a prescriber, not an online forum. At nume, every consultation (including for people returning to treatment) is reviewed the same day by a GPhC-registered prescriber, not software. If you are thinking about whether Wegovy is still the right option for you, our free consultation page is the place to start.